Campbell & Co. Investment Adviser »

Denali Therapeutics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.1M 217k 14.52
2025-06-30 $2.0M 143k 13.99
2025-03-31 $927k 68k 13.60
2024-12-31 $768k 38k 20.38
2023-09-30 $356k 17k 20.63
2023-03-31 $208k 9.0k 23.04

More positions owned by Campbell & Co. Investment Adviser

Wheaton Precious Metals Corp Common Stock (WPM)
Rio Tinto Adr (RIO)
Sprouts Farmers Market Common Stock (SFM)
PTC Common Stock (PTC)
Agnico Eagle Mines Common Stock (AEM)
OGE Energy Corp Common Stock (OGE)
Paychex Common Stock (PAYX)
CMS Energy Corp Common Stock (CMS)
Royal Gold Common Stock (RGLD)
Logitech International SA Common Stock (LOGI)
Franklin Resources Common Stock (BEN)
Meta Platforms Common Stock (META)
Graphic Packaging Holding Common Stock (GPK)
Kinder Morgan Common Stock (KMI)
Pan American Silver Corp Common Stock (PAAS)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Denali Therapeutics

BlackRock
Vanguard Group
Baillie Gifford & Co
FMR
T. Rowe Price Investment Management
Ubs Global Asset Management Americas
State Street Corporation
Temasek Holdings
Capital Research Global Investors
Baker Bros. Advisors
Alliancebernstein
Geode Capital Management
Crestline Management
Holocene Advisors
Point72 Asset Management

View all funds holding Denali Therapeutics